1. Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date

   • Vladimir Lerner
   • Peter J. A. McCaffery
   • Michael S. Ritsner

   Leading Article 11 March 2016 Pages: 269 - 280

   

2. A Review of Pharmacologic Treatment for Compulsive Buying Disorder

   • Célia Soares
   • Natália Fernandes
   • Pedro Morgado

   Review Article 11 April 2016 Pages: 281 - 291

   

3. Unexplained Painful Physical Symptoms in Patients with Major Depressive Disorder: Prevalence, Pathophysiology and Management

   • Jan Jaracz
   • Karolina Gattner
   • Krystyna Górna

   Review Article Open access 05 April 2016 Pages: 293 - 304

4. The Effect of Gabapentin Enacarbil on Quality of Life and Mood Outcomes in a Pooled Population of Adult Patients with Moderate-to-Severe Primary Restless Legs Syndrome

   • Alon Y. Avidan
   • Daniel Lee
   • Richard Kim

   Original Research Article 11 April 2016 Pages: 305 - 316

   

5. Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database

   • Chris Bushe
   • Esther Sobanski
   • Sami Leppämäki

   Original Research Article 07 April 2016 Pages: 317 - 334

   

6. Brexpiprazole: A Review in Schizophrenia

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 29 March 2016 Pages: 335 - 342

   

7. Lisdexamfetamine: A Review in ADHD in Adults

   • James E. Frampton

   Adis Drug Evaluation 05 April 2016 Pages: 343 - 354

   

8. Erratum to: Targeting CGRP: A New Era for Migraine Treatment

   • Stephanie Wrobel Goldberg
   • Stephen David Silberstein

   Erratum 11 April 2016 Pages: 355 - 355